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ALT       →       Argon Laser Trabeculoplasty 
 
BP         →       Blood Pressure 
 
CT         →       Computerized Tomography 
 
DM        →       Diabetes Mellitus 
 
DR        →       Diabetic Retinopathy 
 
HRT      →       Heidelberg Retinal Tomography 
 
IOP       →       Intraocular pressure 
 
MRI       →       Magnetic resonance imaging 
 
NTG      →       Normal tension glaucoma 
 
OH         →       Ocular Hypertension 
 
OAG      →       Open Angle Glaucoma 
 
POAG    →       Primary Open Angle Glaucoma 
 
RBCs    →       Red Blood Corpuscles 
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CLINICAL STUDY OF  PRIMARY OPEN ANGLE  




Primary open angle glaucoma is the commonest form of glaucoma 
accounting for atleast half of all the glaucomas. 
It is also known as chronic open angle glaucoma and chronic simple 
glaucoma. 
It is typically asymptomatic until significant visual field loss has occurred. 
Patients usually present with significant visual field loss in one eye and advanced 
disease in the other. 
Diabetes Mellitus is one of the risk factors for POAG. 
OBJECTIVES 
• To study the hospital based prevalence of POAG among the diabetic patients 
attending Govt. Rajaji Hospital, Madurai Medical College, Madurai.  
• To screen all diabetics for glaucoma. 
METHODS 
One hundred diabetic patients, both insulin dependent and non insulin 
dependent, above forty years of age, attending Govt. Rajaji Hospital,   who came 
directly to Department of Ophthalmology or who were referred here for evaluation, 
between May 2010 and August 2011, were screened for the detection of Primary 
Open Angle Glaucoma. 
RESULTS 
The results of the study show a clear evidence of an excess of POAG in 
diabetic population, which was 4..5 % .The prevalence among males was slightly 
more  (5.1 %) as compared to females (3.12%). 
In my study, the mean age of  POAG among males was 56 yrs and 50.0 yrs 
among females. My studies show that the prevalence of POAG and the duration of 
DM was proportional and that the mean blood glucose level was higher in diabetics 
with POAG. 
KEYWORDS 




 The suggestion of an association between diabetes and Primary Open 
Angle Glaucoma (POAG) is not new. In 1971, Becker stated “Diabetes 
Mellitus occurs more often in patients with primary open angle glaucoma than 
in non-glaucomatous populations. Similarly, Glaucoma is more prevalent in 
diabetic than in non-diabetic population”. 
 Diabetes Mellitus has been suggested as one of the risk factors of 
POAG along with other risk factors. Armstrong et al have reported a 
prevalence of POAG of 4.1% in the diabetic patients. The prevalence of 
diabetes in POAG was 1.7%. Many studies have shown a higher prevalence 
of elevated mean IOP and POAG among persons with diabetes compared to 
those without, and a higher prevalence of individuals with abnormal glucose 
metabolism among glaucoma patients than among the general population. 
Case-control studies have supported an association between diabetes and 
POAG. 
 It is tempting to accept diabetes as a definite risk factor for chronic 
open angle glaucoma, since diabetes is a disease of microangiopathy, and 
compromise of microcirculation of the optic disc is a possible contributing 
mechanism in the pathogenesis of glaucoma. 
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However, a number of studies including population-based investigations have 
not found an association between diabetes and open angle glaucoma. 
Population based prevalence data on association of glaucoma and diabetes 
among  Asians are limited in number and of variable quality. Hence, my aim 
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REVIEW OF LITERATURE 
HISTORY OF GLAUCOMA 
 In the Hippocratic Aphorisms the term glaucoma was used to describe 
blindness coming on in advanced years associated with a glazed appearance 
of the pupil- “If the pupil becomes sea colored, sight is destroyed and 
blindness of the other eye often follows”. 
 Originally, indeed it was undifferentiated from cataract; both diseases 
were located in the lens, then considered the essential organ of vision, and 
both depended on a disturbance of the visual spirits. 
 The first suggestion of a disease associated with a rise in intraocular 
pressure and thus corresponding to what is, now known as glaucoma seems to 
occur in the Arabian writings of At-Tabari (tenth century) who wrote in the 
“Book of Hippocratic treatment” of a chronic inflammatory condition of the 
eye with raised tension, and of Sams-ad-Din (1348) of Cairo, who, among the 
one hundred and fifty three diseases of the eye and its adnexa, described with 
the ophthalmias a “migraine of the eye” or “headache of the pupil”, an illness 
associated with pain in the eye, hemicrania and dullness of the humours, and 
followed by dilatation of the pupil and cataract, if it became chronic, 
tenseness of the eye and blindness supervened. 
12 
 
 It was not until the beginning of the nineteenth century that the first 
excellent description of glaucoma with a raised ocular tension was given by 
Antoinne-Pierre Demours (1818) in a treatise, which incorporated the 
teaching of his father, Pierre Demours, and himself. The clinical picture was 
fully detailed and he described for the first time the appearance of the colors 
of a rainbow around the lights. 
 In London, Guthrie GJ recognized hardness of the eye as a 
characteristic of a disease, which he termed ‘Glaucoma’. The next epoch in 
the history of glaucoma followed the introduction of the Ophthalmoscope, 
when clinical observation on the glaucomatous cup began to accumulate. The 
disease was divided into three categories - acute, chronic and secondary by 
Von Graefe (1857). 
 With the advent of the gonioscope, various others pointed out that 
glaucoma can be divided into two types, one with an open angle and other 
with closed angle. It was Otto Barkan (1938) of San Francisco, who 
suggested that angle closure glaucoma was due to obstruction of flow of 
aqueous through the pupil and advised a peripheral iridectomy to re-establish 
communication between the posterior chamber and anterior chamber as a 
means of surgical cure. From these revolutionary ideas grew the 




Fig. 1: Normal adult anterior chamber angle 
 





CLASSIFICATION OF GLAUCOMAS 
Glaucomas can be classified based on: 
1. The etiology 
• i.e., the underlying disorder that leads to an alteration in aqueous humour 
dynamics. 
2. The mechanism 
• i.e, the specific alteration in the anterior chamber angle that leads to a rise in 
intraocular pressure. 
Primary glaucomas 
These are not consistently associated with obvious systemic or other ocular 
disorders that might account for this alteration. 
• They are usually bilateral. 
• They have a genetic basis. 
Secondary glaucomas 
These are associated with ocular or systemic abnormalities that appear to be 
responsible for the alteration in aqueous humour dynamics. 
• They are unilateral or bilateral 





CLASSIFICATION OF GLAUCOMAS BASED ON ETIOLOGY 
A. PRIMARY GLAUCOMAS 
i. Primary Open Angle Glaucoma 
ii. Primary Angle Closure Glaucoma 
B. DEVELOPMENTAL GLAUCOMAS 
i. Primary Congenital Glaucoma 
ii. Developmental glaucomas with associated anomalies 
• Axenfeld-Rieger Syndrome 
• Peter’s Anomaly 
• Aniridia 
• Other developmental anomalies 
C. SECONDARY GLAUCOMAS 
i. Glaucomas associated with primary disorders of the corneal endothelium 
• Iridocorneal endothelial syndrome 
• Posterior polymorphous dystrophy 
• Fuch’s endothelial dystrophy 
ii. Glaucomas associated with disorders of iris and ciliary body 
• Pigmentary glaucoma • Iridoschisis • Plateau iris • Iris and ciliary body cysts  
iii. Glaucomas associated with disorders of lens 
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• Exfoliation Syndrome 
• Glaucomas associated with cataracts 
• Glaucomas associated with lens dislocation 
iv. Glaucomas associated with disorders of retina, vitreous, choroid 
• Neovascular Glaucoma 
• Glaucomas associated with retinal detachment and vitreoretinal 
abnormalities 
v. Glaucomas associated with elevated episcleral venous pressure 
vi. Glaucomas associated with intraocular tumours 
• Malignant Melanoma  • Retinoblastoma  • Metastatic Carcinoma  • 
Leukemias and lymphomas  • Benign tumours 
vii. Glaucomas associated with ocular inflammation 
• Uveitis  • Keratitis, episcleritis and scleritis 
viii. Steroid – induced glaucomas 
ix. Glaucomas associated with intraocular hemorrhage 
x. Glaucomas associated with ocular trauma 
xi. Glaucomas following ocular surgery 
• Ciliary block (malignant) glaucoma  
• Glaucomas in aphakia and pseudophakia 
• Epithelial, fibrous and endothelial proliferation 
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• Glaucomas associated with corneal surgery 
• Glaucomas associated with vitreoretinal surgery 
CLASSIFICATION OF GLAUCOMAS BASED ON MECHANISM 
A. OPEN ANGLE GLAUCOMAS 
1. Primary Open Angle Glaucomas 
2. Secondary Open Angle Glaucomas 
a. Pretrabecular forms (membrane overgrowth) 
i) Fibrovascular membrane (neovascular glaucoma) 
ii) Endothelial layer, often with Descemet’s like membrane 
• Iridocorneal endothelial syndrome 
• Posterior polymorphous dystrophy 
• Penetrating and non penetrating trauma 
iii) Epithelial down growth 
iv) Fibrous ingrowth 
v) Inflammatory membrane 
• Fuch’s heterochromic iridocyclitis  • Leutic interstitial keratitis 
b. Trabecular forms 
i) Idiopathic 
• Chronic open angle glaucomas 
• Steroid-induced glaucomas 
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ii) Clogging of the trabecular meshwork 
• Red blood cells 
   Hemorrhagic glaucoma      Ghost cell glaucoma 
• Macrophages 
   Hemolytic glaucoma 
   Phacolytic glaucoma 
   Malanomalytic glaucoma 
 • Neoplastic cells 
   Malignant tumours    Neurofibromatosis    Nevus of Ota 
   Juvenile xanthogranuloma 
 
• Pigment particles 
  Pigmentary glaucoma    Exfoliation Syndrome (glaucoma     
     capsulare)    Uveitis    Malignant Melanoma 
• Protein 
   Uveitis     Lens-induced glaucoma 
• Viscoelastic agents 
• Alpha-chymotrypsin induced glaucoma 
• Vitreous 




 • Uveitis (Trabeculitis)  • Scleritis and episcleritis • Alkali burns 
 
b. Trauma (angle recession) 
c. Intraocular foreign bodies (Hemosiderosis, Chalcosis) 
C. Post trabecular forms 
i. Obstruction of Schlemm’s canal 
 • Collapse of canal   • Clogging of canal (e.g. Sickled RBCs) 
ii. Elevated episcleral venous pressure 
 • Carotid cavernous fistula 
 • Cavernous Sinus Thrombosis 
 • Retrobulbar tumour 
 • Thyrotropic exophthalmos 
 • Superior vena cava obstruction 
 • Mediastinal tumours 
 • Sturge-Weber Syndrome 
 • Familial episcleral venous pressure elevation 
3. Developmental Open Angle Glaucomas 
 a. Primary Congenital Glaucoma 
 b. Developmental glaucomas with associated anomalies 
B. ANGLE CLOSURE GLAUCOMAS 
1. Primary Angle Closure Glaucomas 
2. Secondary Angle Closure Glaucomas 
 a. Anterior forms (“Pulling” mechanism) 
i) Contracture of membranes 
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 • Neovascular glaucoma 
 • Iridocorneal endothelial syndrome 
 • Posterior polymorphous dystrophy 
 • Penetrating and non penetrating trauma 
ii) Contracture of inflammatory precipitates 
 b. Posterior forms (“Pushing” mechanism) 
i) With pupillary block 
• Pupillary block glaucoma 
• Lens induced mechanisms 
  Intumescent lens    Subluxation of lens   Mobile lens Syndrome 
• Posterior synechiae 
• Iris-vitreous block in aphakia 
• Pseudophakia 
• Uveitis 
ii) Without pupillary block 
• Plateau Iris Syndrome 
• Ciliary block (Malignant) glaucoma 
• Following lens extraction (forward vitreous shift) 
• Following scleral buckling 
• Following pan retinal photocoagulation 
• Central retinal vein occlusion 
• Intraocular tumours 
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  Malignant Melanoma     Retinoblastoma 
• Cysts of the iris and ciliary body 
• Retrolenticular tissue contracture 
    Retinopathy of prematurity   Persistent hyperplastic  Primary vitreous 
c. Developmental angle closure glaucomas 
i. High insertion of anterior uvea 
• Congenital (infantile) glaucoma 
• Juvenile glaucoma 
• Glaucomas associated with other developmental anomalies 
ii. Incomplete development of trabecular meshwork/Schlemm’s canal 
• Axenfeld-Rieger syndrome 
• Peter’s anomaly 
• Glaucomas associated with other developmental anomalies 
iii. Iridocorneal adhesions 
• Broad strands (Axenfeld-Rieger Syndrome) 
• Fine strands which contract to close angle (Aniridia)4 
PRIMARY OPEN ANGLE GLAUCOMA 
 
 Primary open angle glaucoma is the commonest form of glaucoma 
accounting for atleast half of all the glaucomas. It is also known as chronic 
open angle glaucoma and chronic simple glaucoma. Although the exact 
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etiology is not known, it is likely that genetic defects set of a series of events 
that lead to increased resistance to aqueous outflow and increased 
vulnerability of the optic nerve head to a particular intra ocular pressure level. 
Within this large group of glaucomas, the most common form is typically 
defined by the following three criteria: 
 a. An intraocular pressure (IOP) consistently above 21mm Hg in atleast 
 one eye 
 b. An open, normal appearing anterior chamber angle with no apparent 
 ocular or systemic abnormality that might account for the elevated IOP 
 c. Typical glaucomatous visual field and /or optic nerve head damage5 
 POAG includes several forms: 
I.  “Senile sclerotic glaucoma” which is seen in the elderly and involves 
 relatively low IOPs. 
II.  “High tension glaucoma” which occurs in a younger population and is 
 marked by high pressures. 
III. A third variation maybe “ Normal tension glaucoma”: in which the IOP 
 never exceeds the statistical norms. 
EPIDEMIOLOGY 
Prevalence 
Among Caucasian population POAG is: 
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1. 7% in Baltimore (1985-1988) 
2. 1% in Beaver Dam, Wisconsin (1987-1988) 
1.9% in country Roscommon, Ireland (1988-1989) and 1.1% in Rotter Dam, 
The Netherlands (1991-1993). 
 The Baltimore study and population based studies performed in St. 
Lucia, West Indies (1986) and Barbados, West Indies (1988-89) indicated that 
blacks have a prevalence of open angle glaucoma three or four times higher 
than that of whites, and the  disease manifests at an earlier age among blacks. 
Age specific data showed a marked increase in glaucoma prevalence with 
age. Population based prevalence data on glaucoma among Asians are limited 
in number and of variable quality. Asia comprises heterogeneous groups of 
people and generalizations about all Asians cannot be made from results 
obtained from specific regions. 
 A population based survey conducted in Japan (1988-89) reported 
prevalence of 2.62% for open angle glaucoma. Among these, 78% had IOP 
below 21 mmHg. Their percentage is considerably higher than the 30 to 50% 
obtained in population based studies in the United States and Europe. 
Incidence 
 There is a paucity of adequate data on incidence. Various studies have 




Blindness from Glaucoma 
Fig. 3: Blindness caused by Glaucoma 
 
The Model Reporting Area (MRA) study reported glaucoma blindness 
prevalence of 8.8 per 100,000 for whites and 131.4 per 100,000 for non-
whites in the 45 to 64 age group. These estimates increased with age and were 
261.4 per 100,000 for whites and 746.9 per 100,000 for non whites in the 85 
or older age group. 
 Results from the Baltimore Eye Survey indicated that blindness due to 
open angle glaucoma increased with age among whites and blacks, began ten 
years earlier among blacks, and was the leading cause of non remediable 
blindness among blacks, with an overall age adjusted prevalence 6.6 times 
than among whites. 
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 The overall incidence of new blindness considering the MRA data with 
crosssectional data from the Baltimore eye survey yields an estimate of 
12,000 new cases of blindness every year from glaucoma in the United States. 
Chronic open angle glaucoma as a health problem 
Global health problem of primary open angle glaucoma as per world health 
organization estimations. 
 People with high IOP (>21mm Hg) 104.65 million 
 People with POAG 13.5million 
 Incidence of Glaucoma per year 2.4 million 
 Blindness prevalence for Glaucoma 5.2 million 
 Blindness prevalence for POAG 3 million 
 The different types of glaucoma were theoretically calculated to be 
responsible for 15% of the blindness, placing glaucoma as the third leading 
cause of blindness worldwide. 
RISK FACTORS 
Risk factors with strong supporting evidence 
Age 
 All studies agree that the prevalence of primary open angle glaucoma 
increases with the age of the population being considered. It is unusual for the 
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disorder to reach the clinical stage before the age of 40 (except in juvenile 
open angle glaucoma), and most cases are seen after age 65. 
In one general population survey of 3,000 individuals, the prevalence of 
primary open angle glaucoma and low- tension glaucoma by age group was 
0.22% among 40 to 49 year olds, 0.10% for 50 to 59, 0.57% or 60 to 69, 
2.81% for 70 to 79 and 14.9% for patients above 80 years of age. Age, 
therefore becomes an increasingly significant risk factor with each decade. 
The prevalence of POAG is 3-10 times higher among individuals older than 
80 years (than people in their 40s). 
Race 
Fig 4: Prevalence of open angle glaucoma in different populations 
 
Several studies have shown that primary open-angle glaucoma is more 
prevalent, develops at an earlier age, and is more severe in blacks as 
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compared to whites. Non-whites are said to have seven to eight times more 
blindness from glaucoma than whites. One possible explanation for this racial 
difference in susceptibility to elevated IOP might be the high incidence of 
sickle cell anemia among blacks, increasing the potential for optic nerve head 
ischemia. This theory, however was not supported in a 
 study that found sickle trait in only 2 of 40 blacks undergoing filtering 
surgery for primary open-angle glaucoma. It is hypothesized that larger cup 
disc ratios, large discs and more nerve fibres may be contributory. Asians, 
Canadians, Alaskans, Greenland Inuit Indians, and certain South American 
Indians are at an increased risk for narrow-angle glaucoma. 
Sex 
 The prognostic significance of sex is less clear than that of age and 
race, although several studies suggest a higher prevalence among men. 
Women are at a greater risk for angle-closure glaucoma than men. 
Family history 
 Heritable susceptibility has been shown. Between 10-20% of patients 
with glaucoma have a positive family history. Family history of glaucoma, 
especially in first-degree relatives is important. Family history of glaucoma in 
a sibling is the greatest risk factor, followed by glaucoma in a parent. 
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 The Baltimore Eye Survey found that the relative risk of having 
glaucoma is increased 3.7- fold for individuals who have siblings with POAG. 
Genetics of glaucoma has been shown for the following: 
• POAG – Juvenile onset; genetic linkage mapped to band 1q23. 
• POAG – Adult onset 
• Pigmentary glaucoma- Gene responsible for fragment dispersion 
  syndrome mapped to band 7q35q36. 
• Pseudoexfoliation 
• Aniridia 
• Axenfeld-Rieger Syndrome 
• Primary congenital glaucoma10 
Intraocular pressure 
 Intraocular pressure (IOP) might be defined as that pressure which does 
not lead to glaucomatous damage of the optic nerve head. IOP is a definite 
and important risk factor for developing glaucomatous damage but is not 
sufficient for a diagnosis. The prevalence of POAG is higher with increasing 
IOP. One tenth of patients with ocular hypertension develop field loss within 
10 years. Each year, about 1% of all individuals with increased IOP progress 
to glaucomatous damage. As many as 50% of patients with glaucomatous 
optic neuropathy or visual field changes have IOP of less than 21 mmHg on 
29 
 
initial evaluation. Some eyes undergo damage at IOP of less than 18 mm Hg 
others tolerate IOP of more than 30 mmHg. 
 A pressure of 10-21 mmHg is considered normal; a non-gaussian 
distribution occurs with a skew towards higher pressures. 2-6 mmHg diurnal 
variation of IOP is normal. Greater than 10 mmHg variation is suggestive of 
glaucoma. Peak usually occurs in the morning hours. 
Although the level of intraocular pressure (IOP) is one of the most consistent 
risk factors for the presence of glaucoma, the concept that statistically raised 
IOP is a defining characteristic for glaucoma has been almost universally 
discarded. This is based on several population based studies that document 
the typical disc and field damage of glaucoma in people with a statistically 
normal IOP and, conversely, people with statistically elevated IOP and no 
evidence of optic neuropathy. 
 The distribution of IOP in the general population as studied by Ley 
Decker (normal IOP was statistically defined two standard deviations above 
and below mean, as 11-21 mmHg) is not Gaussian, but is slightly skewed 
towards higher IOP’s. Nearly 10% of the population over 40 years can have 
IOP’s higher than 21 mm Hg, in the presence of open angles and normal optic 




 In the 1996 edition of the American Academy of Ophthalmology, 
preferred practice pattern for POAG, elevation of IOP is neither a component 
of the definition of POAG nor a clinical characteristic of it. IOP has been 
reclassified as a risk factor for the clinical process rather than a clinical 
feature of POAG. 
Risk factors with fair supporting evidence 
Diabetes 
 Open-angle glaucoma (OAG) is an optic neuropathy characterized by 
progressive retinal ganglion cell (RGC) death and optic disc excavation. 
Evidence is accumulating that RGC apoptosis is the fundamental pathology of 
OAG. Among several risk factors for development and progression of OAG, 
inclusion of co-morbid diabetes has been controversial. Recent basic studies 
have shown that diabetes not only affects vascular tissues but also 
compromises neuronal and glial functions and metabolism in the retina, which 
ultimately gives rise to apoptotic death of retinal neurons including RGCs. 
The  impaired metabolism of neurons and glia by diabetes may render RGCs 
susceptible to additional stresses related to OAG such as elevated intraocular 
pressure. Many studies including the Rotterdam study, Netherlands and the 
Blue Mountains eye study, Australia have investigated the possible existence 
of an association between glaucoma and diabetes. 
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 The prevalence of POAG and ocular hypertension is several times 
higher in the diabetic population than in the general population. The 
prevalence of diabetes or a positive glucose tolerance test has also been 
shown to be higher in patients with POAG or a high IOP response to topical 
steroids. Diabetes also appears to influence the nature of visual field loss in 
patients with POAG, with a prevalence of inferior field loss of 64.4% versus 
36.4% in diabetics versus non-diabetics, respectively, and a 32% prevalence 
of diabetes among POAG patients with primarily inferior loss, compared to 
13% in those without such a defect. 
Risk factors with weak supporting evidence 
1. Systemic hypertension 
2. Migraine and Vasospasm 
PATHOGENESIS 
 Elevated intraocular pressure is a feature of POAG. A sustained 
increase in IOP may be due to increased formation of the aqueous humour, 
difficulty in its exit, or a raised pressure in the episcleral veins. Of these, the 
first and last rarely occur, and it follows that raised intraocular pressure is 
essentially due to an increased resistance to the circulation of the aqueous at 
the pupil and/or to its drainage through the angle of the anterior chamber. If 
the outflow pathway via the trabecular meshwork is blocked, some drainage 
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does occur through the uveoscleral outflow, but these alternative channels are 
not efficient and they are incapable of dealing with sudden changes of 
intraocular pressure. 
  Increased IOP in most cases is caused by decreased facility of aqueous 
humour outflow. Increased resistance or reduced facility of outflow is seen 
between anterior chamber and lumen of Schlemm’s canal. Because trabecular 
meshwork prolapses into Schlemms’ canal, it occludes the lumen and 
prevents circumferential flow of aqueous humour to collector channels. 
Obstruction of intrascleral collector channels by accumulation of 
glycosaminoglycans in adjacent sclera. If the trabecular meshwork or 
endothelium of Schlemm’s is the site of increased resistance to outflow in 
POAG, then what process interferes with normal aqueous elimination? 
Theories 
a) Obstruction of trabecular meshwork by foreign material such as pigments, 
RBC’s, glycosaminoglycans, amorphous material, extracellular lysosomes, 
plaque-like material and proteins. 
b) Loss of trabecular endothelial cells.  
c) Loss of giant vacuoles in inner wall of endothelium of Schlemm’s canal.  
d) Decreased permeability of trabecular meshwork 
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e) Loss of normal phagocytic activity, that is, the self – clearing filter property 
of the meshwork.. 
Increased resistance to outflow is linked with: 
i) Altered corticosteroid metabolism Patients with POAG have 
 Increased plasma levels of cortisol 
 Increased suppression of plasma cortisol with different doses 
of exogeneous  dexamethasone. 
 Continued suppression of plasma cortisol by dexamethasone 
– despite concomitant administration of phenytoi. 
 Disturbed pituitary adrenal function 
  Increased inhibition of mitogen stimulated lymphocyte 
transformation by glucocorticoids. 
ii) Dysfunctional adrenergic control  
 Reduced outflow in POAG is due to increased sensitivity to 
adrenergic agonists. 
iii)  Abnormal immunologic processes   
 Reduced outflow is due to increased levels of gamma–globulin 
and plasma cells in trabecular meshwork of patients with POAG; 
and increased antinuclear antibodies. 
iv) Oxidative damage  
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 Trabecular meshwork contains glutathione, which protects 
endothelial cells from effects of hydrogen peroxide and other 
oxidants. 
  Glaucomatous damage to optic nerve in most cases is a result of 
increased IOP. Some nerves, however, can withstand high pressures 
for a remarkably long time, whereas others seem to develop 
pathologic cupping at normal or even low normal intraocular 
pressures. Thus the resistance of nerve head to pressures is a key 
factor that determines whether an individual will develop 
progressive damage. 
Three local characteristics of nerve head play a role in such resistance: 
 • Diameter of scleral ring 
 • Strength of lamina cribrosa 
 • Integrity of vascular supply 
The pathogenesis of glaucomatous damage is attributed to 
i) Vasogenic theory of nerve damage 
This theory implies that structural and functional defects occurring in optic 
nerve head with glaucoma are mainly due to ischemia. 
• Increased IOP leads to reduced capillary blood flow due to 
a) Mechanical compression of vessels at lamina cribrosa 
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b) Reduced flow in annulus of Zinn, which supplies nutrition to laminar and 
post laminar optic nerve head, i.e. increased IOP leads to reduced perfusion 
pressure of the optic nerve. 
• Recently, Anderson put forth the hypothesis that inhibition of autoregulation 
of blood supply to optic nerve can cause increased susceptibility of disc to 
pressure – induced ischemia. 
ii) Mechanical theory of nerve damage 
 The coats of the eye can withstand fairly high intraocular pressures 
except at the lamina cribrosa - the fenestrated region through which optic 
nerve fibres enter the eye. Here, the nerve fibres are supported by glial tissue 
and have to blend over the edge of the disc. 
 Increased IOP leads to mechanical pressure on lamina cribrosa, altering 
capillary blood flow and reduced axoplasmic flow in the initial stages. Later, 
significant backward displacement and compaction of the laminar plates 
narrows the openings through which the axons pass, directly damaging the 
nerve fibre bundles, leading to atrophy. A reduction in blood supply follows 
the tissue atrophy because the atrophied tissue no longer requires nutrition. 
 Dysfunctional axoplasmic transport, because of these mechanical or 
vascular changes, leads to fewer trophic factors reaching the ganglion cells. 
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This causes damage and eventually death of the ganglion cells, which triggers 
apoptosis of adjacent cells. 
Immunologic Studies 
 Increased gamma globulin and plasma cells in the trabecular meshwork 
of eyes with COAG have been reported, and a high percentage of patients 
with this disease were found in one study to have positive antinuclear 
antibodies reactions. These reports suggested a possible immunologic 
mechanism in the pathogenesis of COAG. 
CLINICAL FEATURES 
Symptoms 
 Primary open angle glaucoma is usually described as an insidious, 
slowly progressive, bilateral condition. The adjective “insidious” is 
appropriate because most patients are asymptomatic until the late stages of the 
disease. The few exceptions to this rule include the occasional patient who 
notices a scotoma when performing a monocular visual task, or the young 
patient who has sudden, severe elevations in intraocular pressure that cause 
corneal edema, halo vision and discomfort. If patients are not diagnosed until 
they develop extensive glaucomatous damage, they may become symptomatic 
from loss of fixation in one or both eyes or from loss of peripheral vision, 
which interferes with activities such as driving. The early stages of POAG 
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usually develop slowly over months to years. As glaucoma advances, 
however, the pace accelerates. 
Signs 
1. Elevated intraocular pressure 
 Most patients with POAG have elevated intraocular pressures in the 
range of 22 to 40 mmHg. Some patients have much higher pressures, which 
occasionally reach levels of 60 or even 80 mm Hg. It is important to 
remember that intraocular pressure fluctuates throughout the day and that 
patients with glaucoma undergo wider fluctuations than do normal 
individuals. Although most people reach their highest intraocular pressures in 
the morning, others may reach their peaks in the afternoon or evening or 
follow no consistent pattern. Diurnal intraocular pressure measurements 
maybe useful in some situations, including diagnosing primary open angle 
glaucoma, explaining progressive damage despite apparent good pressure 
control, evaluating the efficacy of therapy, and distinguishing normal tension 
glaucoma from primary open angle glaucoma. 
 Most individuals have fairly symmetric intraocular pressure readings. 
When pressure is higher in one eye, that eye usually has a larger cup and a 





Fig. 1: Normal optic Disc 
 
 




2. Optic disc changes 
The most important variables for early detection of glaucomatous optic nerve 
damage in ocular hypertensive eyes before the development of visual field 
loss are: 
 a. Shape of neuroretinal rim 
 b. Size of optic cup in relation to size of the optic disc 
 c. Decreased visibility of the retinal nerve fibre layer 
 d. Occurrence of localized retinal nerve fibre layer defects and   
     hemorrhages 
 As bundles of axons are destroyed in an eye with glaucoma, the neural 
rim begins to thin in one of several patterns. 
i) Focal atrophy: The inferior temporal rim becomes thinner than the superior 
  temporal rim. The vertical cup-disc ratio becomes more than the horizontal       
  cup disc ratio. The changes in chronological order are: 
Polar notching 
The atrophy of the neural rim often begins as a small discrete defect usually 
in the inferior temporal quadrant. This is also known as focal notching or pit 










Fig.7  Laminar dot sign 
 





Sharpened polar neural edge: 
As the focal notching enlarges and deepens, it may develop a sharp nasal 
margin often adjacent to a major vessel. 
Sharpened rim: 
When local thinning reaches the disc margin there will be no visible neural 
rim in that area. 
Bayoneting sign: 
If a retinal vessel crosses the sharpened rim, it will bend sharply at the edge of 
the disc. 
ii) Concentric atrophy: Enlargement of the cup in concentric circles, most 
often directed inferotemporally or superotemporally. 
Temporal unfolding: Loss of the neural rim tissue usually begins temporally 
and then progresses circumferentially towards the poles. This has been called 
temporal unfolding. This is very difficult to differentiate from the physiologic 
cup. 
Cresentic shadow: A thinning of the neural rim maybe seen as a cresentic 
shadow adjacent to the disc margin as the intense beam of a direct 
ophthalmoscope passes across the neural rim. It should not be confused with 
the grey crescent. 
iii) Deepening of the cup: In some cases the predominant pattern of early 
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glaucomatous atrophy is a deepening of the cup. 
Overpass cupping: The vessels initially bridge the deepened cup and later 
collapse into it. 
Laminar dot sign: Exposure of lamina cribrosa by the deepening cup is 
recognized by grey fenestra of lamina, which has been referred to as laminar 
dot sign. 
iv) Pallor /Cup discrepancy 
 In the early stage of glaucomatous optic atrophy, enlargement of the 
cup may progress ahead of that of the area of pallor. This biphasic pattern 
differs from other causes of optic atrophy in which the area of pallor is 
typically larger than the cup. 
Saucerization: Refers to a pattern of glaucomatous change in which diffuse, 
shallow cupping extends to the disc margin with retention of central pale cup. 
Focal saucerization: More localized, shallow, sloping cup. 
Tinted hallow: Retention of normal neural rim colour in the area of focal 
saucerization has been called tinted hallow. 
Shadow sign:As the glaucomatous damage progresses, the colour is replaced 
by grayish hue termed shadow sign. 
v) Advanced glaucomatous cupping: Bean-pot cupping: In advanced cases all 




Fig.5  Drance Hemorrhage 
 
Fig 6. Advanced cupping in concentric atrophy end stage glaucoma 
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as a white disc with loss of all neural rim tissue and bending of vessels at the 
margin of the disc. It is called bean pot because on histologic examination, 
there will be a posterior displacement of lamina cribrosa and undermining of 
the disc margin. 
Vascular Signs 
i) Optic disc hemorrhages 
 Splinter hemorrhages, usually near the margin of the optic nerve head 
are a common feature of glaucomatous damage.. 
ii) Tortuosity of retinal vessels 
 Maybe seen on the disc with advanced glaucomatous optic atrophy. It 
represents loops of collateral vessels in response to chronic central retinal 
vessel occlusion. 
iii) Location of retinal vessels in relation to the cup 
 a) Overpass cupping: The vessels initially bridge the deepened cup  
 and later collapse into it. 
 b) Baring of the circumlinear vessels: In many normal optic nerve 
 heads one or two vessels may curve to outline a portion of the 
 physiologic cup. With glaucomatous enlargement of the cup, the 




iv) Nasal displacement of the retinal vessels 
 Does not provide a useful diagnostic parameter. 
Peripapillary changes associated with glaucomatous optic atrophy 
i) Nerve fibre bundle defects 
 The loss of axonal bundles produces visible defects in nerve fibre layer 
which appears as dark stripes of varying width in the peripapillary area 
paralleling the normal retinal striations. 
ii) Peripapillary depigmentation 
  Seen both in normal as well as patients with glaucoma. It is called as 
peripapillary halo, peripapillary atrophy or chorioscleral crescent. It occurs 
more frequently and is larger in glaucomatous damage as compared to normal 
eyes and it has been observed to enlarge progressively in eyes with glaucoma. 
3. Gonioscopy 
 By traditional definition, the anterior chamber angle in eyes with 
POAG is open and grossly normal. Preliminary studies, however, suggest that 
these patients may have more iris processes, a higher insertion of the iris root, 
more trabecular meshwork pigmentation and a greater than normal degree of 





4. Visual field abnormalities 
a. Generalized depression of visual field 
 Diffuse reduction in visual threshold is one of the earliest detectable 
alterations in the visual field of a patient with glaucoma. But they are non-
specific of glaucoma. Concentric contraction of the visual field, which is 
more marked in the nasal field, is called “crowding of the peripheral nasal 
isoptres”. 
Enlargement of the blind spot: also considered as an early field change 
which is non specific for glaucoma. 
Angioscotoma: are long, branching scotomas above and below the blind spot, 
which are presumed to result from shadows created by large retinal vessels. 
Other measures of generalized visual impairment in glaucoma: Other 
psychological tests that support the concept that a generalized decrease in 
visual function may be the earliest visual change in glaucoma are 
i. Colour vision 
 Reduced sensitivity to colour may precede any detectable loss of 
peripheral or central vision. The colour vision deficit is associated primarily 
with blue sensitive pathways. The clinical usefulness of colour vision in the 




ii. Contrast sensitivity 
 Subtle loss of both central and peripheral vision can be demonstrated in 
some patients with glaucoma prior to detectable visual field change. 
iii. Electrophysiological studies 
 Electroretinography shows reduced amplitude. 
 Visually Evoked Potential – Reduced response to high flicker VEP 
 Electrooculography – shows increased baseline values 
iv. Miscellaneous tests 
 Dark adaptation – is abnormal. 
 A relative afferent pupillary defect. 
 Reduced brightness comparison test. 
b. Nerve fibre bundle defects 
 Focal defects resulting in loss or impairment of retinal nerve fibre 
bundles are more specific for glaucoma and constitute the most definitive 
early evidence of visual field loss from these disorders. 
i. Scatter: Areas where there is a variable threshold response to repeated 
testing in the same area. This has been referred as scatter, fluctuation or 
localized minor effects. Scatter is not a definite sign of glaucoma. 
49 
 
ii. Arcuate defect: Early visual loss in glaucoma commonly occurs within 
arcuate area. They most often appear first as one or more localized defects or 
paracentral scotoma. 
• Siedel’s scotoma: Early arcuate defect may connect with the blind spot and 
taper to a point in a slightly curved course. 
• Arcuate or Bjerrum scotoma: As the isolated defects enlarge and coalesce, 
they form an arching scotoma that eventually fills the entire arcuate area from 
the blind spot to the median raphe. 
• Ring scotoma or double arcuate scotoma: When two arcuate scotoma from 
above and below meet. 
• Nasal step: The loss of retinal nerve fibres rarely proceeds at the same rate 
in the upper and lower portions of the eye. Consequently, a step like defect is 
frequently created where the nerve fibres meet along the median raphe. Since 
the superior field is involved more frequently than the inferior portion in the 
early stages of glaucoma, most common is the superior nasal step. 
• Central nasal step: Created at the nasal termination of unequal double 
arcuate scotoma. 
iii. Peripheral field defects 
  Peripheral nasal step of Roenne: Unequal contraction of peripheral 
isoptres produce this defect. 
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  Vertical step: A stepwise defect along vertical midline is referred to as 
vertical step or hemianopic offset. It is less common. 
 Temporal sector defect: The retinal nerve fibres nasal to the optic nerve 
head converges on the disc by a direct route. A lesion involving these 
fibre bundles produce a sector defect temporal to the blind spot. They 
usually appear in later stages of glaucoma. 
c. Advanced glaucomatous field change 
 Visual field is reduced to central and temporal island of vision. The 
temporal island of vision is more resistant and persists long after central 
vision is lost. 
Correlation between optic nerve head and visual field defects 
 Clinically recognizable disc changes precede detectable field loss. The 
extent of axonal loss is much greater than the corresponding visual field 
change. Upto 35% of the fibres maybe gone in one eye with normal field, 
while more than half the fibres maybe lost by the time reproducible early field 
defects are found, and 10% of fewer axons may remain by the stage of severe 
field loss. The nature of optic nerve head cupping can also be used to predict 
the type of field loss. Extensive or focal absence of neural rim tissue 
especially at the inferior or superior pole is the most reliable indicator of 
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visual field disturbance and is usually associated with a field defect in the 
corresponding arcuate area. 
 In general, optic nerve head and retinal nerve fibre layer changes have 
their greatest value in the early stages of glaucoma, while progressive visual 
field loss becomes the more useful guide to therapy in advanced cases. 
DIAGNOSIS 
A diagnosis of POAG can be made after performing the following tests: 
1. Intraocular pressure recording 
2. Optic nerve head assay 
3. Gonioscopy 
4. Visual field analysis 
Intraocular pressure recording 
 Tonometer is the instrument used to measure the intraocular pressure. 
All clinical tonometers measure the IOP by relating a deformation of the 
globe to the force responsible for the deformation. The two basic types of 
tonometers differ according to the shape of the deformation: indentation and 
applanation (flattening). 
1. Schiotz Indentation Tonometer - a known weight used to indent 
the cornea. 








 The shape of deformation with these tonometers is a simple flattening, 
and because the shape is constant, its relationship to the IOP can be derived 
from mathematical calculations.  
Goldmann applanation Tonometry 
 Goldmann based his concept on tonometry on a modification of the 
Maklakov- Fick law (also referred to as the Imbert Fick Law). This law states 
that an external force (W) against a sphere equals the pressure in the sphere 
(P1) times the area flattened (applanated) by the external force (A):         
W=P1 x A It was  necessary to modify the Imbert-Fick law in the following 
manner to account for the characteristics of the cornea: W+S=P1A1 + B 
Where A1 =7.35 mm2, S balances B and W=P. The instrument is mounted on 
a standard slit lamp in such a way that the examiner’s view is directed 
through the center of a plastic biprism, which is used to applanate the cornea. 
Two beam –splitting prisms within the applanating unit optically convert the 
circular area of corneal contact into semicircles. The prisms are adjusted so 
that the inner margins of the semicircles overlap when 3.06 mm of cornea is 
applanated. Other applanation tonometers with variable force: 
1.Hand-held Goldmann-type tonometers 
2.Perkins Applanation tonometer: 
3.Drager Applanation tonometer: 
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The IOP varies with age, time of the day and with the measurement methods. 
This variation in the IOP is very significant for the management of POAG. A 
wide fluctuation of IOP on diurnal measurement is suggestive of glaucoma 
and a control of the peak pressure is essential for a good control of POAG. 
These measurements of IOP should be conducted over 24 hours on an 
inpatient, outpatient or self-tonometry basis.  
Provocative Tests 
The water-drinking test is a test in which outflow channels of the eye are 
stressed to provoke a distinction between normal eyes and those with risk of 
POAG. Spaeth and Vacharat have shown that the rise of pressure in this test is 
dependent on the baseline IOP and so a positive test could have a correlation 
to glaucomatous field changes. 
Optic Nerve Head Assay 
 Stereophotography of the optic nerve head is at present the best way to 
ascertain small changes sequentially. A diagrammatic representation of the 
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disc, detailing the cupdisc ratio, status of the neuroretinal rim, e.g. width, 
irregularity, colour, vascular alterations and a documentation of any nerve 
layer defects at every follow-up should be mandatory. 
Other methods of assessing nerve fibre layer 
 In the clinical evaluation of the optic nerve head, the direct 
ophthalmoscope is very useful, especially when looking through a small pupil 
or evaluating the nerve fibre layer with a red-free filter (green-filter 
ophthalmoscopy).The other methods used are : 
Stereochromoscopy 
Stereochromoscopy utilizes the stereoscopic principle to detect subtle changes 
in photographs of a disc taken at different times. If there has been any 
progression of the cupping, the disparity in the cup margins of the 
superimposed photographs will produce a stereoscopic effect. A modification 
of this concept, referred to as stereochronometry, uses a stereo plotter to 
measure the changes created by the two photos. Other techniques for 
detecting differences in serial fundus photographs involve analysis of flicker 
while alternately viewing one photograph and then the other, and electronic 






 Colorimetric measurements have also been studied in an effort to detect 
reduced or changing colour intensity of the optic nerve head. A photographic 
technique has also been developed to permit quantitative evaluation of the 
relative brightness of the illuminated optic nerve head. 
Ultrasonography 
 Ultrasound can be used to detect glaucomatous cupping of 0.7 cup/disc 
ratio or greater, and high –resolution contact B –scan echography may one 
day provide a reliable estimate of the optic cup size in eyes with opaque 
media. 
Confocal Laser Scanning 
This is a technique for obtaining high-resolution images by using a focused 
laser beam to scan over the area of the fundus to be imaged. By scanning the 
fundus with the laser, a two-dimensional image can be built up as an array of 
pixels ( confocal scanning laser ophthalmoscopy). If a series of such images 
are obtained at successive planes of depth in the tissue, these can be used to 
construct a three-dimensional image (confocal scanning laser tomography). 
Optical Retinal Tomography 
 The principle of optical coherence tomography (OCT) involves a low-
coherence infrared (843 nm) diode light source, which is divided into 
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reference and sample paths. Reflected sample light from the subject’s eye 
creates an interference signal with the reference beam, which is detected in a 
fibreoptic interferometer. Cross-sectional images of the retina and disc are 
then constructed from a sequence of signals, similar to an ultrasound B mode. 
Preliminary studies have demonstrated that nerve fibre layer thickness can be 
measured using the OCT. 
Heidelberg Retinal Tomography 
 Conventional perimetry is insensitive to ganglion cell loss. 50% of 
ganglion cells are located 20 degrees around fovea. Heidelberg Retinal 
Tomography (HRT) is a confocal scanning laser ophthalmoscope for 
acquiring and analyzing three-dimensional images of posterior segment. The 
optic nerve head and peripapillary retina are scanned in two directions. In 
thirty-two planes, two million data points are obtained and all are 
reconstructed to give a topographic picture. 
Rasterstereography 
 “Raster” simply refers to a scanning pattern that moves from side-to-
side and from top-to-bottom (the same scanning pattern used in confocal laser 
scanning). In rasterstereography, a series of horizontal dark/light line pairs are 
projected on the disc and peripapillary retina at a fixed angle, and the 
computer scans a video image of the lines in a raster fashion. Since the lines 
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are deflected proportional to the height or depth of the disc and retinal 
surfaces, a computer algorithm can translate the deflections into depth 
numbers and create a topographic map. 
Gonioscopy 
 It is an important confirmatory technique, distinguishing POAG from 
creeping angle closure glaucoma and other secondary glaucomas. This is 
performed using an indirect goniolens of either the Goldmann or Zeiss 4 
mirror type. 
Perimetry 
 The term perimetry is used to describe techniques employed to examine 
and quantify the visual field using targets of various sizes and colours. Visual 
field testing is generally performed by adapting the eye fully corrected for the 
testing distance with full field lenses, to a photoptic background 
illuminiscence over which is superimposed a brighter test stimulus in a kinetic 
or static manner. 
  This maybe accomplished by using kinetic and /or static techniques 







 This method involves moving the test object from a non-seeing to a 
seeing area and recording the point at which it is first seen in relation to 
fixation. The procedure documents the boundaries of the visual field, for both 
the absolute limits as well as area of relative differences in visual acuity 
within the field. Types of kinetic perimeters are Listers’ perimeter and 
Goldmann’s perimeter. 
Static techniques 
 This approach involves the presentation of stationary test objects 
utilizing either suprathreshold or threshold presentations. 
 Goldmann perimetry is the present standard for normal visual field 
assessment, allowing standardization of background illumination and stimulus 
intensity, reproducible positioning of the stimulus and fixation monitoring. 
For Goldmann perimetry the patient should be comfortably positioned and the 
threshold determined on the 25 degrees isopter, 15 degrees above and below 
the temporal horizontal meridian. 12e is the standard test stimulus used for the 
central 5-15 degrees isopters and the nasal and temporal meridians, which are, 
examined minutely both by static and kinetic perimetry techniques. The depth 
of any scotoma, relative or absolute, is ascertained by gradually increasing 
stimulus size / intensity. The peripheral field is charted using the 14e 
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stimulus. Automated computerized perimetry is a more accurate and more 
informative technique for glaucomatous field evaluation. 
Automated Perimeters 
 Automated computerized perimetry is a more accurate and informative 
technique for glaucomatous field evaluation. Those, which have received the 
most reported investigation, are the Delta program with the Octopus perimeter 
and the STATPAC with the Humphrey Field Analyzer. In case of the 
Humphrey Field Analyzer, the STATPAC uses a large normal database, while 
STATPAC II uses a database of stable glaucoma patients. The STATPAC II 
also includes linear regression analysis and glaucoma change probability. A 
third statistical algorithm with the Humphrey Field Analyzer is the Progressor 
Program for analysis of serial fields downloaded to a personal computer. 
MANAGEMENT 
Indications for treatment 
 Generally, the ophthalmologist institutes treatment when the patient has 
the classic glaucoma triad of visual field loss, optic nerve cupping and 
elevated intraocular pressure. 
Goals of treatment 
 No definitive procedure exists for POAG, so one must aim at 
controlling the disease rather than curing it. When treating POAG, the 
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ophthalmologist attempts to stop the progression of the disease or to slow it 
sufficiently to maintain good vision for the patient’s lifetime. The goal is 
usually achieved by lowering intraocular pressure.  
Medical therapy 
 POAG has traditionally been thought of as a medical disease. The basic 
principle of medical therapy is to use the least amount of medicine that will 
control the glaucoma with the fewest side effects.  
Anti-glaucoma drugs 
Classification 
• Parasympathomimetic drugs (Miotics) 
• Sympathomimetic drugs (adrenergic agonists) 
• Beta blockers 
• Carbonic anhydrase inhibitors 
• Hyperosmotic agents 
• Prostaglandins 
• Calcium channel blocker 
Parasympathomimetic drugs 
Preparations: 
1. Pilocarpine: 1%, 2% and 4% eye drops 4% gel Ocuserts 
2. Carbachol: 0.75% and 3% eye drops 
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3. Ecothiophate iodide: 0.03, 0.06 and 0,125% eye drops 
4. Demecarium bromide: 0.125% ,0.25% eye drops 
5. Physostigmine: 0.5% ointment 
Sympathomimetic drugs 
They act by stimulation of alpha, beta or both the receptors. 
Preparations 
1. Epinephrine: 0.5%, 1% and 2% eye drops 
2. Dipivefrine: 0.1% eye drops 
3. Clonidine hydrochloride: 0.125% and 0.25% eye drops 
4. Brimonidine 0.2% eye drops 
5. Apraclonidine : 0.5% and 1% drops 
Beta-adrenergic blockers 
 These are presently the most frequently used anti-glaucoma drugs. 
Preparations 
1. Timolol: 0.25% and 0.5% eye drops 
2. Betaxolol: Cardioselective beta-blockers 
0.25% and 0.5% suspension 
3. Levobunolol: 0.5% eye drops 
4. Carteolol: 1% and 2% eye drops 
5. Metipronolol: 0.1%, 0.3% and 0.6% eye drops 
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Carbonic anhydrase inhibitor (CAIs) 
These are potent and most commonly used anti-glaucoma drugs. 
Preparations: 
1. Acetazolamide: 250 mg tablets 
2. Dichlorphenamide: 50mg tablets 
3. Methazolamide: 50mg tablets 
4. Ethoxzolamide: 125 mg tablets 
5. Dorzolamide: Topical carbonic anhydrase inhibitor 2% eye drops 
Hyperosmotic agents 
These are second class of compounds, which are administered systemically to 
lower the IOP. 
Preparations: 
1. Glycerol: 50% solution 




Latanoprost : 0.005% 
Mechanism of action: 
1. Increasing uveoscleral outflow 
2. Causes reduction in episcleral venous pressure 
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Calcium channel blockers 
 Verapamil 0.125% and 0.25% eye drops Mechanism of action: Not 
known. It might be due to its effects on secretory ciliary epithelium.  
Tolerance and compliance with medical therapy 
 Surgical intervention is usually indicated whenever there is progressive 
glaucomatous damage despite “maximum tolerable medical therapy”. 
Surgical intervention 
 When the glaucoma is uncontrolled medically, laser trabeculoplasty is 
usually the first surgical procedure of choice, followed by incisional surgical 
intervention when necessary. Trabeculectomy is usually the preferred 
incisional surgical technique for POAG.  
 Trabeculectomy lowers the intraocular pressure by creating a fistula 
between the inner compartments of the eye and the subconjunctival space 
(i.e., filtering bleb). The fistula is protected or guarded by a superficial scleral 
flap. 
 In non-penetrating filtration surgery, the anterior chamber is not 
entered, thusreducing the incidence of postoperative over filtration and 
hypotony. The two currently used procedures are deep sclerostomy, in which 
bleb formation often occurs and viscocanalostomy, in which bleb formation is 
infrequent. Aqueous drainage devices are generally reserved as a last resort 
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for patients with glaucoma that is refractory to standard filtering surgery. This 
includes patients with extensive conjunctival scarring, chronic inflammation 
and ocular trauma. IOP lowering with glaucoma drainage devices is generally 
not as effective as with filtering surgery. Cyclophotocoagulation is another 
alternative for patients with glaucoma that is refractory to other interventions 


















 Two hundred diabetic patients, both insulin dependent and non insulin 
dependent, above forty years of age, attending GOVT. RAJAJI HOSPITAL 
Madurai, who came directly to Department of Ophthalmology or who were 
referred here for evaluation, between May 2010 and August 2011, were 
screened for the detection of Primary Open Angle Glaucoma. 
Patients who satisfied any one of the inclusion criteria were selected. 
Inclusion criteria 
• IOP > 21 mmHg (by Schiotz tonometry) with visual field defects. 
• IOP > 21 mmHg (by Schiotz tonometry) with optic nerve head changes. 
• Optic nerve head changes with visual field defects. 
• Normal IOP with no visual field defects or optic nerve head changes, with 
  asymmetry of IOP in both eyes of > 5 mmHg. 
Exclusion criteria 
• Closed angle on gonioscopy 
• Drug induced (corticosteroids) 
 The diabetic patients above 40 years of age were briefly explained 
about the study and the tests they would have to undergo. These patients were 
subjected to detailed eye examination in the Department of Ophthalmology, 
Govt. Rajaji Hospital Madurai. 
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These examinations include: 
 Visual acuity 
 Slit lamp examination 
 Tonometry with Schiotz tonometer, diurnal testing 
 Ophthalmoscopy 
 Gonioscopy 
 Visual field testing using Automated perimeter (Octopus /Humphrey) 
 Patients with significant disc cupping (and other signs of glaucomatous 
 disc changes), with field defects, regardless of IOP were suspected as 
 having POAG. IOP was recorded to allow distinction between POAG 
 with elevated pressure and Normal Tension Glaucoma. Criteria for 
 diagnosis of ocular hypertension were pressure greater than 21 mmHg, 
 with no disc changes, and in the absence of field defect. 
METHOD OF STATISTICAL ANALYSIS 
 The following methods of statistical analysis have been used in this 
study. The results were averaged (mean±standard deviation) for continuous 






1. One way Analysis of Variance (ANOVA) 
 One way analysis of variance was used to test the difference between 
groups. Analysis of Variance is a technique by which the total variation is 
split into two parts one between groups and the other within the groups. If ‘F’ 
value is significant, there is a significant difference between group means. To 
find out which of the two groups means is significantly different post hoc test 
of LSD test is used. In case F value is not significant it indicates that there is 
no significant difference between the groups and stops the analysis at this 
stage and does not use LSD test. 
The formula used: where MS=Mean Sum of Square 
2. Univariate analysis of the dichotomous variables encoded was performed    
    By means of the Chi square test with Yates correction if required. 
Chi-Square (γ2) test for (2 x 2 tables) 







Male a b a+b 
Female c d c+d 







 a, b, c, d are the observed numbers. 
N is the Grand Total γ2 with 1 DF  
DF=(r-1)*(c-1), where r=rows and c=columns 
DF= Degrees of Freedom (Number of observation that are free to vary after 
certain restriction have been placed on the data). 
3. Student “t’ test 
 The student ‘t’ test was used to determine whether there was a 
statistical difference between male and female subjects in the parameters 
measured. Student’s t test is as follows: t= ~~~ t n1+n2-2  
In all the above tests, p values less than 0.05 were taken to be statistically 













 200 diabetic patients with 64 (32.0%) females and 136 (68.0%) males 
were included in the study. All the subjects were studied in terms of age, IOP, 
duration of diabetics and blood glucose level. The observations were made in 
both eyes of all the subjects. 
Table 1 Age and sex distribution of diabetics in the study group 
Age group 
 




 Female ( %) Male ( %) 
 
 
40-49 20(33.3) 40(66.7) 60 
50-59 30(31.9) 64(68.1) 94 
60-69 10(25.0) 30(75.0) 40 
>=70 4(66.7) 2(33.3) 06 
Total 64 136 200 
Statistic DF Value Prob 
Chi-Square 3 2.1319 0.5455 
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Table 2-Sex-wise distribution of patients with POAG 
Sex 
 














Males 136 7(5.1) 4(2.9) 0 125(91.9) 
Females 64 2(3.1) 0 2(3.1) 60(93.8) 
 
Total 200 9(4.5) 4(2.0) 2(1.0) 185(92.5) 
 
 This table shows the proportion of cases diagnosed among diabetic 
patients in the study population. Overall proportion of POAG cases observed 
was 4.5% (9 out 200), NTG observed 2.0% (4 out of 200) and 1.0% OH cases 
were observed remaining 93% were normal. Among the males 5.1% (7 out of 
136) and females 3.12% (2 out 64) POAG cases were diagnosed. The 
proportion of POAG cases diagnosed between males and females was not 
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  RELATIONSHIP BETWEEN PREVALENCE OF POAG  
AND OTHER VARIABLES IN DIABETIC  CASES  
Table 4 :  
Age group POAG 
Present Absent 
No % No % 
< 50 years (60) - - 60 100 
50- 59 years (94) 6 6.4 88 93.6 
60-69 years (40) 2 5.0 38 95 
>  70 yrs (6) 1 16.7 5 83.3 
Total 9 4.5 191 95.5 
Mean 56.2 52.8 years 
SD 6.6 years 8.5 years 
‘p’ 0.2826  
Not significant 
 
 The patients with POAG had an age of 56.2 +6.6 years. The cases 
without POAG had an age of 52.8 +8.5 years. There was no statistically 






Table 8 -Age-wise distribution of POAG among the diabetic population 
studied 
Age group Male Female Total 
 
40-49 - - - 
50-59 4 2 6 
60-69 2 - 2 
>=70 1 - - 
Total 7 2 9 
 
 The above table shows the age distribution among POAG patients (9 
out of 200). The mean age of the patients was 54.5±4.80 ranging from 50 yrs 
to 61 yrs. The mean age of male patients was 56.0± 4.58 ranging from 52 yrs 
to 61 yrs. The mean age of female patients was 50.0 years. 






  RE LE 
 
55 Male 31.8 25.1 
50 Female 23.8 22.4 
52 Male 25.1 22.4 
61 Male 23.1 25.1 
50 Female 23.8 22.4 
61 Male 23.1 25.1 
55 Male 31.8 25.1 
52 Male 25.1 22.4 
70 Male  22.4 22.4 
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lower IOP than POAG and OH patients (p<0.05) but no significant difference 
is seen between NTG and Normal (p>0.05). The POAG patients had 
statistically significant higher IOP than Normal. 
 The Mean Left eye IOP values of Normal were 17.79±2.55. The mean 
IOP values of NTG were 16.9±0.57. The mean IOP values of POAG were 
25.82 +4.98. The mean IOP values of OH were 25.1. The difference observed 
in mean IOP values among the group was statistically significant (p<0.05). 
 The further analysis of comparison of mean IOP between the groups 
(initial diagnosis) revealed that the NTG patients had statistically significant 
lower IOP than POAG and OHT patients (p<0.05) but no significant 
difference is seen between NTG and Normal (p>0.05). The POAG patients 


















































































































POAG NTG OH N 
 
40-49 0 0 0 60 60 
50-59 6 4 0 84 94 
60-69 2 0 2 36 40 
>=70 1 0 0 3 03 
Total 9 4 2 185 200 
 
The study population consists of 136 (68.0%) male and 64(32.0%) female in 
the age range from 40-73 years with mean age of 53.1±8.28 years. The total 
number of  diabetic patients observed in 40 to 29 years is 60 (30.0%), 50 to 
59 years 94(47.0%), 60-69 years 40 (20.0%) and >70 years 6 (3.0%). The 
majority of the diabetics are above 50 years age. 
 The table shows that the proportion of POAG is more in patients above 
50 years age. It also shows the prevalence of NTG is more in patients in the 








Table 8- Comparison of mean blood glucose level among diabetics with 










FBS 200.25 115.51 4.21 <0.01 
 
PPBS 305.75 198.41 3.65 0.0004 
 
 
Fig 7: Comparison of mean blood glucose level among diabetics with 






















































































































































Table 10- Proportion of POAG among Diabetic patients with retinopathy 
Sex DR POAG Percentage 
 
Male 34 4 11.8 
Female 20 0 0 
Total 54 4 7.4 
 
 The above table shows the proportion of POAG among those having 
diabetic retinopathy. Overall 7.4% (4 out 54) POAG patients had diabetic 
retinopathy. Among males it was observed that 11.8% (4 out of 34) were 
diagnosed as POAG, and among females no patients were diagnosed as 
POAG. It was observed that proportion was more in male diabetics than in 
females. 
 




















 This table shows the proportion of Diabetic retinopathy among diabetic 
patients in the study population. Overall proportion of cases observed was 
27.0% (54 out 200). Among the males 25.0% (34 out of 136) and females 
31.3% (20 out 64) cases were observed. The proportion of Diabetic 
retinopathy observed between males and females was not statistically 
significant (p>0.05). 
Statistical Tools  
The information collected regarding all the selected cases were 
recorded in a Master Chart. Data analysis was done with the help of computer 
using Epidemiological Information Package (EPI 2010) developed by 
Centre for Disease Control, Atlanta.  
 Using this software range, frequencies, percentages, means, standard 
deviations, chi square and  'p'  values were calculated. Kruskul Wallis chi-
square  test was used to test the significance of difference between 
quantitative variables and Yate’s chi square test for qualitative variables. A 'p' 







 The discussion of an association between Diabetes and POAG is not 
new. In 1971 Becker stated “Diabetes Mellitus occurs more often in patients 
with Primary Open Angle Glaucoma than in non-glaucomatous populations. 
Similarly, Glaucoma is more prevalent in diabetic than in non-diabetic 
population”.Considerable controversy exists in literature.  
 While several studies show an association between the two diseases, 
several others fail to show any significant association. Most of these studies 
were comparatively small, used differing definitions of glaucoma and were 
clinical, rather than community based. A prevalence of 3.11 from Rotterdam, 
1.84 from Wisconsin and 2.12 from Australia  have been reported. Armstrong 
et al have reported a prevalence of POAG of 4.1 % in diabetic patients. The 
prevalence of diabetes in POAG is 1.7 %. A community based study 
conducted in Vellore, South India showed a prevalence of POAG of 4.1% in 
diabetics. 
 My study shows a clear evidence of an excess of POAG in diabetic 
population, which is 4.5 % .The prevalence among males, is slightly more 
(5.1 %) as compared to females (3.12%). In my study, the mean age of POAG 
among males was 54.5 yrs and 50.0 yrs among females. My studies show that 
the prevalence of POAG and the duration of DM is proportional and that the 
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mean blood glucose level is higher in diabetics with POAG. Screening all 
diabetic patients for POAG at the time of annual screening for retinopathy is 
an attractive proposition provided a clear clinical benefit could be 
demonstrated. A screening test should ideally be relatively inexpensive, 
simple, and quick to perform and if possible be capable of being administered 


















 Primary Open Angle Glaucoma is characterized by its adult onset, IOP 
> 21mm Hg at some point in the course of the disease, open normal angle, 
glaucomatous optic nerve damage and visual field loss. It affects 1 in 100 
people above 40 years of age. Diabetes Mellitus is one of the risk factors for 
POAG along with others such as positive family history, high myopia, black 
race etc. Various studies have addressed this question with some studies 
upholding and some refuting a link between the two diseases. Studies among 
Asians are limited and most studies are population based. In my study I found 
a significant association between POAG and Diabetes. I found a moderate 
excess of prevalence of POAG among patients with diabetes and that this was 
proportional to the duration of Diabetes. These findings are compatible with 
studies that have demonstrated an association between the two diseases. 
 Primary Open Angle glaucoma is typically asymptomatic until 
significant visual field loss has occurred. Patients usually present with 
significant visual field loss in one eye and advanced disease in the other. It is 
clearly evident from my study that diabetic patients are indeed at significant 






1. Primary Open Angle glaucoma is typically asymptomatic until 
significant visual field loss has occurred.  
2. Patients usually present with significant visual field loss in one 
eye and advanced disease in the other.  
3. It is associated with irreversible blindness.  
4. Thus, the public health importance of detecting undiagnosed and 
treatable glaucoma is important, as blindness has economic and 
societal consequences for the rest of an individual’s life.  
5. Several studies have shown an association between POAG and 
diabetes.  
6. From my study, I come to a conclusion that there is an excess of 
POAG in diabetic population, which is 4.5% (as compared to 
2.1% in normal population), thereby showing an association 
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A CLINICAL STUDY OF PRIMARY OPEN ANGLE GLAUCOMA IN 







• Presenting Complaints: 
• History of presenting complaints: 
• Medical history: 
• Past history: 
• Treatment history: 
• Family history: 
• Personal history: 






GENERAL PHYSICAL EXAMINATION 
SYSTEMIC EXAMINATION 
OCULAR EXAMINATION: 
1. Visual acuity RE 
LE 
2. External ocular examination 
• Head posture 










3. Fundus Examination 
• Media 




• Retinal blood vessels 
• Background 
 
4. Diagnostic tests 
a. Tonometry ( by Schiotz indendation tonometer )  
b. Slit Lamp Examination 
c. Gonioscopy 
d. Perimetry ( by Octopus 300 field analyser )  




















KEY TO MASTER CHART 
Sl. No.  → Serial number 
OP.No.  → Outpatient number 
M   → Male 
F   → Female 
DM   → Diabetes Mellitus 
yrs   → Years 
RE   → Right Eye 
LE   → Left Eye 
IOP   → Intraocular pressure 
A.S   → Anterior Segment 
N   → Normal 
A   → Absent 
P   → Present 
DR   → Diabetic Retinopathy 
Glau.   → Glaucomatous 
Gonio  → Gonioscopy 
FBS   → Fasting Blood Sugar 
PPBS  → Postprandial blood sugar 
POAG  → Primary open angle Glaucoma 
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NTG   → Normal Tension Glaucoma 
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